The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant Staphylococcus aureus Disease in San Francisco, 2004–2005
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a major public health problem in both the community and hospitals. Few studies have characterized the incidence and clonal composition of disease-causing strains in an entire population. Our objective was to perform a population-based survey of the clinical and molecular epidemiology of MRSA disease in San Francisco, California. METHODS: We prospectively collected 3985 MRSA isolates and associated clinical and demographic information over a 12-month period (2004-2005) at 9 San Francisco-area medical centers. A random sample of 801 isolates was selected for molecular analysis. RESULTS: The annual incidence of community-onset MRSA disease among San Francisco residents was 316 cases per 100,000 population, compared with 31 cases per 100,000 population for hospital-onset disease. Persons who were aged 35-44 years, were men, and were black had the highest incidence of community-onset disease. The USA300 MRSA clone accounted for 234 cases of community-onset disease and 15 cases of hospital-onset disease per 100,000 population, constituting an estimated 78.5% and 43.4% of all cases of MRSA disease, respectively. Patients with community-onset USA300 MRSA versus non-USA300 MRSA disease were more likely to be male, be of younger age, and have skin and soft-tissue infections. USA300 strains were generally more susceptible to multiple antibiotics, although decreased susceptibility to tetracycline was observed in both community-onset (P = .008) and hospital-onset (P = .03) USA300 compared to non-USA300 strains. CONCLUSIONS: The annual incidence of community-onset MRSA disease in San Francisco is substantial, surpassing that of hospital-onset disease. USA300 is the predominant clone in both the community and hospitals. The dissemination of USA300 from the community into the hospital setting has blurred its distinction as a community-associated pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Outpatient rates of community-associated MRSA infection increased sevenfold over 1999 -2006 in the USA, and subsequently became a signi fi cant cause of MRSA infections within the hospital setting [3, 11].”
From Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Self-citationLina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodMethicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285 · cited 3×
“Many studies characterizing community-associated MRSA and the USA300 strain have focused on outbreaks in particular groups [12–16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688 · cited 5×
“other studies [2, 7, 17, 38], incidence of community-onset MRSA was the highest in a younger age group (35–44 years).”
BackgroundResultInfluentialDiep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633 · cited 6×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundMethodInfluentialSelf-citationMethicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493 · cited 4×
“1086/587893 MRSA clone has become a primary cause of community-associated disease [2, 7, 8] and an increasingly important source of health care–associated infection [9, 10].”
BackgroundResultInfluentialHerold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412 · cited 1×
“Since the late 1990s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant pathogen in the community [1–6].”
BackgroundOliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343 · cited 1×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundShopsin, B., Gomez, M., Montgomery, S. O., Smith, D. H., Waddington, M., Dodge, D. E., Bost, D. A., Riehman, M., Naidich, S., & Kreiswirth, B. N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3556-3563.1999 · Cited by 984 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodCommunity-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00005 · Cited by 776 · cited 3×
“Many studies characterizing community-associated MRSA and the USA300 strain have focused on outbreaks in particular groups [12–16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundSeybold, U., Kourbatova, E. V., Johnson, J. G., Halvosa, S. J., Wang, Y. F., King, M. D., Ray, S. M., & Blumberg, H. M. (2006) · Clinical Infectious Diseases · doi:10.1086/499815 · Cited by 695 · cited 1×
“1086/587893 MRSA clone has become a primary cause of community-associated disease [2, 7, 8] and an increasingly important source of health care–associated infection [9, 10].”
BackgroundFrazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Self-citationDiep, B. A., Stone, G. G., Basuino, L., Graber, C. J., Miller, A., Etages, S. D., Jones, A., Palazzolo‐Ballance, A. M., Perdreau‐Remington, F., Sensabaugh, G. F., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587907 · Cited by 422
Self-citationDiep, B. A., Chambers, H. F., Graber, C. J., Szumowski, J. D., Miller, L. G., Han, L. L., Chen, J. H., Lin, F., Lin, J., Phan, T. H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00204 · Cited by 391
Self-citationGroom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360 · cited 1×
“Since the late 1990s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant pathogen in the community [1–6].”
BackgroundGorak, E. J., Yamada, S. M., & Brown, J. D. (1999) · Clinical Infectious Diseases · doi:10.1086/520437 · Cited by 332
Miller, L. G., & Diep, B. A. (2008) · Clinical Infectious Diseases · doi:10.1086/526773 · Cited by 318 · cited 1×
“The biology and pathogenesis of community-associated MRSA appear to differ from health care–associated MRSA as nonnasal sites of colonization may play an important role in infection [41].”
BackgroundSelf-citationDiep, B. A., Carleton, H. A., Chang, R. F., Sensabaugh, G. F., & Perdreau‐Remington, F. (2006) · The Journal of Infectious Diseases · doi:10.1086/503777 · Cited by 310 · cited 1×
“Since 2001, a dramatic increase in the number of MRSA infections has been observed in 1 San Francisco, California, medical center [20, 28].”
BackgroundSelf-citationBartlett, J. G. (2004) · Infectious Diseases in Clinical Practice · Cited by 266
Community‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Carleton, H. A., Diep, B. A., Charlebois, E. D., Sensabaugh, G. F., & Perdreau‐Remington, F. (2004) · The Journal of Infectious Diseases · doi:10.1086/425019 · Cited by 227 · cited 2×
“Incidence and Molecular Epidemiology of MRSA • CID 2008:46 (1 June) • 1645 The impact of the USA300 strain on MRSA disease in San Francisco is dramatic and particularly remarkable, given that USA300 was first detected in San Francisco only 3 years before the initiation of the study [20].”
BackgroundSelf-citationCommunity-acquired Methicillin-resistant Staphylococcus aureus among Military Recruits
Zinderman, C. E., Conner, B., Malakooti, M. A., LaMar, J. E., Armstrong, A., & Bohnker, B. K. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030604 · Cited by 226 · cited 1×
“breaks in particular groups [12-16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundGates, G. J., & Ost, J. (2004) · Cited by 211
Fifteen-Year Study of the Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus
Crum, N. F., Lee, R. U., Thornton, S. A., Stine, O. C., Wallace, M. R., Barrozo, C., Keefer-Norris, A., Judd, S., & Russell, K. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.004 · Cited by 204 · cited 1×
“medical centers [7, 8, 17-26] and is quite substantial Received 16 November 2007; accepted 14 January 2008; electronically published 23 April 2008.”
BackgroundKourbatova, E. V., Halvosa, J. S., King, M. D., Ray, S. M., White, N., & Blumberg, H. M. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.06.006 · Cited by 197 · cited 1×
“1086/587893 MRSA clone has become a primary cause of community-associated disease [2, 7, 8] and an increasingly important source of health care–associated infection [9, 10].”
BackgroundCommunity-associated Methicillin-resistant Staphylococcus aureus and Healthcare Risk Factors
Klevens, R., Morrison, M., Fridkin, S., Reingold, A., Petit, S., Gershman, K., Ray, S., Harrison, L., Lynfield, R., Dumyati, G., et al. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1212.060505 · Cited by 196 · cited 1×
“7 hospital-onset cases per 100,000 population) [27].”
Huang, H., Flynn, N. M., King, J. H., Monchaud, C., Morita, M., & Cohen, S. H. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00254-06 · Cited by 186
Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections
Kaplan, S. L. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000164162.00163.9d · Cited by 175
Hota, B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1026 · Cited by 172 · cited 2×
“These demographic characteristic correlates likely reflect the underlying predictors of transmission of this disease which include crowded living conditions, frequent close contact, and/or contact with an active case or carrier [17, 18, 38].”
BackgroundAnalyses of clonality and the evolution of bacterial pathogens
Feil, E. J., & Enright, M. C. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.04.002 · Cited by 160 · cited 1×
“net/) [32].”
Self-citationSzumowski, J. D., Cohen, D. E., Kanaya, F., & Mayer, K. H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01244-06 · Cited by 143 · cited 1×
“medical centers [7, 8, 17-26] and is quite substantial Received 16 November 2007; accepted 14 January 2008; electronically published 23 April 2008.”
BackgroundChavez-Bueno, S., Bozdogan, B., Katz, K., Bowlware, K. L., Cushion, N., Cavuoti, D., Ahmad, N., McCracken, G. H., & Appelbaum, P. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2283-2288.2005 · Cited by 124
Goering, R. V., McDougal, L. K., Fosheim, G. E., Bonnstetter, K. K., Wolter, D. J., & Tenover, F. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00273-07 · Cited by 115 · cited 5×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
MethodInfluentialCommunity-associated Methicillin-resistant Staphylococcus aureus , Minnesota, 2000–2003
Buck, J., Como-Sabetti, K. J., Harriman, K. H., Danila, R., Boxrud, D. J., Glennen, A., & Lynfield, R. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.050141 · Cited by 97 · cited 1×
“medical centers [7, 8, 17-26] and is quite substantial Received 16 November 2007; accepted 14 January 2008; electronically published 23 April 2008.”
BackgroundLarsen, A. R., Stegger, M., Goering, R. V., Sørum, M. E., & Skov, R. L. (2007) · Eurosurveillance · doi:10.2807/esm.12.02.00682-en · Cited by 82 · cited 1×
“However, given that this clone has demonstrated potential for spread throughout other communities and to other countries [40], San Francisco is a case study of the continued rising burden of MRSA disease in the community, which now exceeds disease that occurs in the hospital by 10-fold.”
BackgroundIntermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
Graber, C. J., Wong, M. K., Carleton, H. A., Perdreau‐Remington, F., Haller, B. L., & Chambers, H. F. “. (2007) · Emerging infectious diseases · doi:10.3201/eid1303.060960 · Cited by 81 · cited 1×
“In addition, we have reported a case of intermediate vancomycin susceptibility in a methicillin-resistant USA300 strain [39].”
BackgroundSelf-citationBratu, S., Landman, D., Gupta, J., Trehan, M., Panwar, M., & Quale, J. M. (2006) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-5-29 · Cited by 68 · cited 1×
“These demographic characteristic correlates likely reflect the underlying predictors of transmission of this disease which include crowded living conditions, frequent close contact, and/or contact with an active case or carrier [17, 18, 38].”
Hasty, M. B., Klasner, A., Kness, S., Denmark, T. K., Ellis, D., Herman, M. I., & Brown, L. (2006) · Academic Emergency Medicine · doi:10.1197/j.aem.2006.08.008 · Cited by 49
Facts and Findings from The Gay and Lesbian Atlas
Gates, G. J. (2004) · Cited by 3
Research works printed but not linked: 5
- Centers, 2003, MMWR, 52, 793
- Centers, 2001, MMWR, 50, 919
- Centers, 2003, MMWR, 52, 992
- Centers, 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- 10.1111/j.1553-2712.2007.tb00368.x · doi:10.1111/j.1553-2712.2007.tb00368.x
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
“Because of the prominence of toxin activity in these infections, protein synthesis inhibition may also be desirable [54, 55].”
BackgroundLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
“community and in health care facilities [7, 8].”
Self-citationWaves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
“CA-MRSA clones have also gained a foothold in hospitals and are increasingly being identified as a cause of hospital-onset and heath care-associated infection”
BackgroundSelf-citationDavid, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Metadata
- Authors
- Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., Gordon, S., Gunthorpe, H., Jacobs, R., Jensen, P., Leoung, G., Rumack, J. S., & Chambers, H. F.
- Affiliations
- San Francisco General Hospital (US)
- Imperial College London (GB)
- California Pacific Medical Center (US)
- St. Mary's Medical Center (US)
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Saint Francis Memorial Hospital (US)
- Seton Medical Center (US)
- Corresponding author
- Liu, Catherine
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06
- Volume
- 46
- Issue
- 11
- Pages
- 1637-1646
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2098229782
- Cited by
- 205
- References
- 41
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 5 · 2015: 17 · 2014: 13 · 2013: 21 · 2012: 28
- FWCI
- 16.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- Centers for Disease Control and Prevention
- U.S. Public Health Service (CCR923381)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- methicillin-resistant Staphylococcus aureus, USA300 clone, molecular epidemiology, clonal composition, antibiotic susceptibility, tetracycline resistance, skin and soft tissue infections, San Francisco
- MeSH terms
- Adult, Female, Humans, Male, Population Surveillance, Prospective Studies, San Francisco, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, Methicillin Resistance, Community-Acquired Infections, Molecular Epidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.